SCM
Stonebridge Capital Management Portfolio holdings
AUM
$256M
1-Year Return
15.25%
This Quarter Return
-1.73%
1 Year Return
+15.25%
3 Year Return
+71.85%
5 Year Return
+125.65%
10 Year Return
+234.74%
AUM
$273M
AUM Growth
-$7.87M
(-2.8%)
Cap. Flow
+$6.9M
Cap. Flow
% of AUM
2.52%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
146
New
7
Increased
29
Reduced
51
Closed
10
Top Buys
| 1 |
Amgen
AMGN
|
$8.08M |
| 2 |
IBM
IBM
|
$3.98M |
| 3 |
TotalEnergies
TTE
|
$2.09M |
| 4 |
Baker Hughes
BKR
|
$1.5M |
| 5 |
GE Aerospace
GE
|
$930K |
Top Sells
| 1 |
Apple
AAPL
|
$8.62M |
| 2 |
Sabra Healthcare REIT
SBRA
|
$701K |
| 3 |
Palo Alto Networks
PANW
|
$491K |
| 4 |
Estee Lauder
EL
|
$469K |
| 5 |
Bank of America
BAC
|
$399K |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 20.14% |
| 3 | Industrials | 13.48% |
| 4 | Energy | 11.74% |
| 5 | Consumer Staples | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Devon Energy
DVN
$22.1B
| $1.14M | 0.42% |
33,865
+7,450
| +28% | +$250K |
|
52
Becton Dickinson
BDX
$55.1B
| $1.13M | 0.41% |
5,151
| – | – |
|
53
AbbVie
ABBV
$375B
| $1.11M | 0.41% |
12,132
| – | – |
|
54
Abbott
ABT
$231B
| $1.1M | 0.4% |
18,826
| – | – |
|
55
McDonald's
MCD
$224B
| $1.07M | 0.39% |
6,600
-170
| -3% | -$27.5K |
|
56
Kimberly-Clark
KMB
$43.1B
| $1.03M | 0.38% |
9,700
| – | – |
|
|
MON
57
DELISTED
Monsanto Co
MON
| $963K | 0.35% |
7,680
| – | – |
|
|
AGN
58
DELISTED
Allergan plc
AGN
| $944K | 0.35% |
5,746
+1,064
| +23% | +$175K |
|
|
VAR
59
DELISTED
Varian Medical Systems, Inc.
VAR
| $934K | 0.34% |
7,740
-1,984
| -20% | -$239K |
|
|
RDS.B
60
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $902K | 0.33% |
12,894
| – | – |
|
61
GSK
GSK
$81.5B
| $864K | 0.32% |
+17,026
| New | +$864K |
|
|
SJR
62
DELISTED
Shaw Communications Inc.
SJR
| $838K | 0.31% |
40,200
+11,675
| +41% | +$243K |
|
63
Avery Dennison
AVY
$13.1B
| $829K | 0.3% |
7,908
| – | – |
|
|
UN
64
DELISTED
Unilever NV New York Registry Shares
UN
| $821K | 0.3% |
14,400
-150
| -1% | -$8.55K |
|
65
Regeneron Pharmaceuticals
REGN
$60.8B
| $750K | 0.27% |
2,333
+605
| +35% | +$194K |
|
66
Biogen
BIIB
$20.6B
| $707K | 0.26% |
2,661
-75
| -3% | -$19.9K |
|
|
LLL
67
DELISTED
L3 Technologies, Inc.
LLL
| $704K | 0.26% |
3,348
| – | – |
|
68
Invesco
IVZ
$9.81B
| $670K | 0.25% |
21,950
+3,425
| +18% | +$105K |
|
69
DuPont de Nemours
DD
$32.6B
| $661K | 0.24% |
4,950
| – | – |
|
70
Conagra Brands
CAG
$9.23B
| $622K | 0.23% |
16,900
| – | – |
|
71
BCE
BCE
$23.1B
| $619K | 0.23% |
14,500
+4,900
| +51% | +$209K |
|
72
Vertex Pharmaceuticals
VRTX
$102B
| $601K | 0.22% |
3,722
| – | – |
|
73
Norfolk Southern
NSC
$62.3B
| $593K | 0.22% |
4,445
| – | – |
|
74
National Grid
NGG
$69.6B
| $591K | 0.22% |
11,201
-1,021
| -8% | -$53.9K |
|
75
Sanofi
SNY
$113B
| $543K | 0.2% |
+13,387
| New | +$543K |
|